Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet QUINAPRIL/HIDROCLOROTIAZIDA AUROBINDO 20 / 25mg film-coated tablets
- Product code:
- W56255013
- Quantity:
- 98
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- quinapril + hydrochlorothiazide (ACE inhibitor + diuretic)
- ATC
- C09BA06 — Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
The combination of quinapril and hydrochlorothiazide is used for the treatment of high blood pressure. Quinapril is an angiotensin-converting enzyme (ACE) inhibitor that relaxes blood vessels, while hydrochlorothiazide is a diuretic that helps eliminate excess fluid from the body.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to monitor blood pressure and electrolyte levels during treatment.
Side effects may include dizziness, cough, fatigue, electrolyte imbalances, or, in rare cases, severe allergic reactions or kidney failure.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney disease or diabetes, to ensure the safe use of this combination.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to monitor blood pressure and electrolyte levels during treatment.
Side effects may include dizziness, cough, fatigue, electrolyte imbalances, or, in rare cases, severe allergic reactions or kidney failure.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney disease or diabetes, to ensure the safe use of this combination.
General data about QUINAPRIL/HIDROCLOROTIAZIDA AUROBINDO 20 / 25mg
- Substance:
- quinapril + hydrochlorothiazide
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W56255013
- Concentration:
- 20 / 25mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 98
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for quinapril + hydrochlorothiazide
- 10/12.5mg
- 10mg/12.5mg
- 20/12.5mg
- 20/25mg
- 20mg/12.5mg
- 20mg/25mg